Ben E.E.M. van den Borne

Author

Also Known As

B. E. E. M. van den Borne, B.E.E.M Van Den Borne, B.E.E.M. van den Borne, BEN E.E.M. VAN DEN BORNE, Ben E E M Van Den Borne, Ben E E M van den Borne, Ben E. E. M. van den Borne, Ben E.E.M. van den Borne

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Radboud University Nijmegen Catharina Ziekenhuis Maastricht University The Netherlands Cancer Institute University Medical Center Groningen

About

Ben E.E.M. van den Borne is an author at Radboud University Nijmegen specializing in medicine, oncology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	2.2K
2	Public Health	3	3	177
3	Health Sciences	1	1	38
4	Anesthesia	1	1	133
5	Cardiothoracic Surgery	1	1	12

Ben E.E.M. van den Borne

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials Joe Y. Chang, Suresh Senan, Marinus A. Paul, The Lancet Oncology Surgical OncologyRadiation TherapyMedicineRandomised TrialsBronchial Neoplasm	2015	1.4K
Segmental spinal anaesthesia for cholecystectomy in a patient with severe lung disease André van Zundert, G.N. Stultiëns, J. J. Jakimowicz, British Journal of Anaesthesia Spinal Cord InjurySegmental Spinal AnaesthesiaAnesthesia PracticeSevere Lung DiseaseThoracic Surgery	2006	133
Correlates of osteoporosis in chronic obstructive pulmonary disease: An underestimated systemic component Lidwien Graat‐Verboom, Martijn A. Spruit, Ben E.E.M. van den Borne, Respiratory Medicine Bone DiseaseBone HealthUnderestimated Systemic ComponentRheumatoid ArthritisMedicine	2009	114
Randomized, Placebo-Controlled Phase III Study of Docetaxel Plus Carboplatin With Celecoxib and Cyclooxygenase-2 Expression As a Biomarker for Patients With Advanced Non–Small-Cell Lung Cancer: The NVALT-4 Study Harry J.M. Groen, Hannie Sietsma, Andrew Vincent, Journal of Clinical Oncology	2011	107
Patient reported outcomes following stereotactic ablative radiotherapy or surgery for stage IA non-small-cell lung cancer: Results from the ROSEL multicenter randomized trial Alexander V. Louie, Erik van Werkhoven, Hanbo Chen, Radiotherapy and Oncology Surgical OncologyRadiation TherapyMedicineOutcomes ResearchBronchial Neoplasm	2015	98
Interobserver Variability for the WHO Classification of Pulmonary Carcinoids Dorian R.A. Swarts, Robert‐Jan van Suylen, Michael A. den Bakker, The American Journal of Surgical Pathology	2014	97
Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study Karlijn de Joode, Daphne W. Dumoulin, Jolien Tol, European Journal of Cancer EpidemiologyCancer EpidemiologyMedicineGlobal HealthCancer Management	2020	77
Progression of osteoporosis in patients with COPD: A 3-year follow up study Lidwien Graat‐Verboom, Frank W.J.M. Smeenk, Ben E.E.M. van den Borne, Respiratory Medicine Bone Disease3-Year FollowMedicineOsteoporosisPulmonary Disease	2012	66
Risk factors for osteoporosis in Caucasian patients with moderate chronic obstructive pulmonary disease: A case control study Lidwien Graat‐Verboom, Frank W.J.M. Smeenk, Ben E.E.M. van den Borne, Bone Case Control StudyClinical EpidemiologyCaucasian PatientsChronic Disease PreventionCohort Study	2012	57
Negligible influence of comorbidity on prognosis of patients with small cell lung cancer: A population-based study in the Netherlands M.L.G. Janssen‐Heijnen, V.E.P.P. Lemmens, Ben E.E.M. van den Borne, Critical Reviews in Oncology/Hematology EpidemiologyPopulation-based StudyCancer EpidemiologyMedicineEpidemiology Of Cancer	2007	43

Page 1